Joint collaboration with Ryvu Therapeutics
About the poster
This poster, presented at SBI2 2024 and created in collaboration between Ardigen and Ryvu Therapeutics, showcases an innovative AI-based approach for predicting cancer cell proliferation from microscopy images. Using a deep learning model trained on DAPI-stained nuclei images, the team demonstrates that proliferation can be assessed without the need for EdU staining, significantly reducing cost and increasing throughput. The method maintains high accuracy across different cell lines, offering a promising tool for phenotypic drug screening in complex co-culture systems.
